FDA Alignment to Advance ProstACT Global Phase 3 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. INTU
3. DKS
4. META
5. ZM
6. SMTC
7. SPY
8. JAZZ
9. NCNO
10. CRWD

Go back to FDA Alignment to Advance ProstACT Global Phase 3 Trial
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.13 -0.56 (4.79%)
Previous Close $11.69    52 Week High $2.18 
Open $11.26    52 Week Low $0.30 
Day High $11.34    P/E N/A 
Day Low $11.07    EPS $-3.32 
Volume 123,297       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.13 -0.56 (4.79%)
Previous Close $11.69    52 Week High $2.18 
Open $11.26    52 Week Low $0.30 
Day High $11.34    P/E N/A 
Day Low $11.07    EPS $-3.32 
Volume 123,297